Full history for every metric is available with a Kvantra account
Sapporo Clinical Laboratory Inc. (9776.T)
Key financial summary
Financials in JPY| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | ¥bn | 18 | 18 | 19 | 20 | 20 | 20 | 20 |
| Operating profit | ¥bn | 1 | 1 | |||||
| Net profit | ¥bn | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
| EPS reported | ¥ | 148.4 | 124.0 | |||||
| Operating cashflow per share | ¥ | 233.7 | 0.00 | |||||
| Capex per share | ¥ | 390.7 | 0.00 | |||||
| FCF per share | ¥ | -157.1 | 0.00 | |||||
| Free cash flow | ¥bn | -0 | 0 | |||||
| Net debt | ¥bn | -1 | -2 | |||||
| Book value equity | ¥bn | 11 | 11 | |||||
| Book value per share | ¥ | 3,566 | 3,675 | |||||
| Number of shares | m | 3.13 | 3.12 | |||||
| DPS (TTM paid) | ¥ | 23.00 | 23.00 |
Financial summary
Financials in JPY| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | 6.60 | 15.74 | |||||
| P/B LTM | x | 0.27 | 0.53 | |||||
| P/S LTM | x | 0.15 | 0.30 | |||||
| P/FCF LTM | x | -6.24 | 0.00 | |||||
| EV/EBITDA LTM | x | 1.63 | 3.22 | |||||
| EV/Sales LTM | x | 0.10 | 0.22 | |||||
| Earnings Yield LTM | % | 15.15% | 6.35% | |||||
| FCF Yield | % | -16.03% | 0.00% | |||||
| Quality | ||||||||
| ROE | % | 4.16% | 3.43% | |||||
| ROIC | % | 3.39% | 3.41% | |||||
| Operating margin | % | 3.51% | 3.55% | |||||
| Gross margin | % | 29.58% | 30.30% | |||||
| FCF/Sales | % | -2.44% | 0.00% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | +29.98% | -10.08% | |||||
| Sales Growth YoY | % | +2.28% | +1.41% | |||||
| Net Income Growth YoY | % | +22.10% | -11.11% | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | +32.10% | +9.46% | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 2.50% | 1.18% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 16.51% | 16.51% | |||||
| FCF/Debt | x | -0.25 | 0.00 | |||||
| Net Debt/EBITDA | x | -0.80 | -1.20 | |||||
| EBIT/Net interest | x | 105.64 | 110.87 | |||||
| Net debt/market cap | % | -48.16% | -27.04% | |||||
| Net debt/Equity | x | -0.13 | -0.14 | |||||
| Gross debt/equity | x | 0.17 | 0.15 | |||||
Company overview
Established in Sapporo, Japan in 1965, Sapporo Clinical Laboratory Inc. operates a network of dispensing pharmacies across the country. The company provides an extensive array of diagnostic services, including clinical, pathological, and Holter examinations. Its services also extend to environmental health, offering food hygiene assessments that cover processed products, facility cleanliness, and food handler practices, as well as radiation safety management. Furthermore, Sapporo Clinical Laboratory Inc. develops, markets, and maintains specialized software, such as SCAN clinical testing systems. It also delivers support for establishing new clinics and offers the HiWeb21 platform for accessing inspection results. Additionally, the company provides ongoing sales and maintenance for a variety of clinical testing software solutions.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Sapporo Clinical Laboratory Inc. (9776.T)
Established in Sapporo, Japan in 1965, Sapporo Clinical Laboratory Inc. operates a network of dispensing pharmacies across the country. The company provides an extensive array of diagnostic services, including clinical, pathological, and Holter examinations. Its services also extend to environmental health, offering food hygiene assessments that cover processed products, facility cleanliness, and food handler practices, as well as radiation safety management. Furthermore, Sapporo Clinical Laboratory Inc. develops, markets, and maintains specialized software, such as SCAN clinical testing systems. It also delivers support for establishing new clinics and offers the HiWeb21 platform for accessing inspection results. Additionally, the company provides ongoing sales and maintenance for a variety of clinical testing software solutions.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free